$29.570
+1.295 (+4.38%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RAPP Prediction & Forecast by Similar Chart Analysis
Alphio's RAPP stock price prediction model matches the current Rapport Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $30.10 (+1.79%). The 1-week path is $30.48 (+3.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Rapport Therapeutics Inc Stock?
Rapport Therapeutics Inc is a good buy right now due to its current price of $30.65, significantly below the average analyst price target of $65, which suggests a potential upside of over 100%. Additionally, the company has a strong cash position of $436 million, which can support its operations through 2029, despite recent losses. The main risk is the widening net loss reported in Q2 of $56.6 million, which raises concerns about financial sustainability.
RAPP stock price ended at $29.57 on Thursday, after rising +4.38%
Rapport Therapeutics Inc (RAPP) last closed at $29.57, gaining +4.38%. These facts feed the 1-day and 1-week RAPP price prediction above.
Forecast Drivers
Rapport Therapeutics Inc (RAPP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RAPP, ranked by similarity.
Seasonality analysis for RAPP
Historically the probability of a positive October return for RAPP is 87.72%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RAPP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $11.59 | $13.51 | $13.94 | -54.31% |
| Nov 2026 | $13.96 | $15.06 | $17.94 | -49.08% |
| Dec 2026 | $13.60 | $15.18 | $17.69 | -48.66% |
In 2026, Rapport Therapeutics Inc (RAPP) is projected to range from $11.59 to $17.94.
Rapport Therapeutics Inc 2026 monthly forecast
In Oct 2026, Rapport Therapeutics Inc is projected to average $13.51, with a low of $11.59 and high of $13.94.
In Nov 2026, Rapport Therapeutics Inc is projected to average $15.06, with a low of $13.96 and high of $17.94.
In Dec 2026, Rapport Therapeutics Inc is projected to average $15.18, with a low of $13.60 and high of $17.69.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.